CARDINAL HEALTH INC - Common Stock (CAH) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CAH on NYSE
Shares outstanding
238,949,120
Price per share
$205.50
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
205,480,691
Total reported value
$32,208,564,653
% of total 13F portfolios
0.02%
Share change
+718,789
Value change
+$30,241,790
Number of holders
1,204
Price from insider filings
$205.50
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CARDINAL HEALTH INC - Common Stock (CAH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $2,582,660,388 18,774,792 BlackRock, Inc. 31 Jan 2025
BlackRock Portfolio Management LLC 5% +6% $1,875,272,694 +$102,944,413 11,947,456 +5.8% BlackRock Portfolio Management LLC 30 Sep 2025

As of 30 Sep 2025, 1,204 institutional investors reported holding 205,480,691 shares of CARDINAL HEALTH INC - Common Stock (CAH). This represents 86% of the company’s total 238,949,120 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CARDINAL HEALTH INC - Common Stock (CAH) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 31,464,655 +3% 0.09% $4,938,692,215
VANGUARD GROUP INC 13% 30,823,483 +0.81% 0.07% $4,838,053,892
STATE STREET CORP 5.1% 12,287,733 -3% 0.07% $1,928,682,572
GEODE CAPITAL MANAGEMENT, LLC 2.7% 6,485,089 +1.5% 0.06% $1,013,908,455
WELLINGTON MANAGEMENT GROUP LLP 2.4% 5,804,090 +153% 0.16% $911,009,966
FMR LLC 2.3% 5,420,038 -14% 0.04% $850,729,387
MORGAN STANLEY 2.2% 5,230,317 -4.4% 0.05% $820,950,734
BANK OF AMERICA CORP /DE/ 1.5% 3,592,775 +3.2% 0.04% $563,921,919
Invesco Ltd. 1.5% 3,483,207 +15% 0.09% $546,724,207
NORTHERN TRUST CORP 1.2% 2,926,088 -2.3% 0.06% $459,278,772
JPMORGAN CHASE & CO 1.2% 2,898,738 +15% 0.03% $454,986,109
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.1% 2,515,013 -2.5% 0.09% $394,756,442
VICTORY CAPITAL MANAGEMENT INC 0.96% 2,284,115 +45% 0.22% $352,164,513
Legal & General Group Plc 0.89% 2,138,565 -9% 0.08% $335,669,166
MILLENNIUM MANAGEMENT LLC 0.83% 1,984,424 +55% 0.25% $311,475,191
GOLDMAN SACHS GROUP INC 0.83% 1,977,614 +24% 0.04% $310,406,351
PRICE T ROWE ASSOCIATES INC /MD/ 0.82% 1,967,697 +21% 0.03% $308,851,000
BNP PARIBAS FINANCIAL MARKETS 0.82% 1,956,749 0% 0.24% $307,131,323
Holocene Advisors, LP 0.81% 1,926,170 +141% 0.69% $302,331,643
Man Group plc 0.67% 1,605,349 +26% 0.49% $251,975,579
BARCLAYS PLC 0.66% 1,584,214 +109% 0.09% $248,658,229
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.65% 1,552,347 +2% 0.04% $243,656,385
AMERIPRISE FINANCIAL INC 0.61% 1,455,196 +33% 0.05% $228,466,974
Bank of New York Mellon Corp 0.6% 1,440,898 -2.2% 0.04% $226,163,427
Qube Research & Technologies Ltd 0.58% 1,374,083 -3.2% 0.31% $215,676,068

Institutional Holders of CARDINAL HEALTH INC - Common Stock (CAH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,145,252 $442,056,252 +$248,060,496 $205.50 88
2025 Q3 205,480,691 $32,208,564,653 +$30,241,790 $156.96 1,204
2025 Q2 204,989,696 $34,414,795,368 +$96,702,646 $168.00 1,238
2025 Q1 205,242,688 $28,260,366,846 -$605,534,362 $137.77 1,136
2024 Q4 209,672,106 $24,807,217,111 -$299,782,897 $118.27 1,089
2024 Q3 210,509,139 $23,263,375,433 -$364,012,824 $110.52 1,008
2024 Q2 212,798,556 $20,916,059,715 -$313,233,525 $98.32 1,000
2024 Q1 216,051,956 $24,163,995,719 +$507,609,218 $111.90 1,046
2023 Q4 211,939,329 $21,372,855,862 -$326,674,788 $100.80 1,029
2023 Q3 214,756,883 $18,664,651,813 -$364,982,333 $86.82 940
2023 Q2 216,659,526 $20,491,930,293 -$189,998,281 $94.57 937
2023 Q1 221,321,764 $16,723,399,474 -$185,967,683 $75.50 896
2022 Q4 224,671,560 $17,276,898,533 -$840,696,142 $76.87 918
2022 Q3 235,571,453 $15,736,821,673 +$177,056,692 $66.68 825
2022 Q2 232,761,917 $12,190,007,665 +$34,056,411 $52.27 775
2022 Q1 233,502,904 $13,258,180,269 -$48,302,923 $56.70 763
2021 Q4 234,259,829 $12,074,000,131 -$400,055,103 $51.49 759
2021 Q3 241,518,462 $11,958,032,302 -$189,402,923 $49.46 727
2021 Q2 245,102,774 $13,999,099,788 +$42,471,161 $57.09 770
2021 Q1 243,725,922 $14,811,693,023 -$127,512,735 $60.75 783
2020 Q4 246,487,715 $13,207,490,966 -$47,431,897 $53.56 761
2020 Q3 248,194,162 $11,657,416,192 -$188,022,365 $46.95 723
2020 Q2 251,005,590 $13,101,812,951 +$62,158,862 $52.19 751
2020 Q1 249,457,377 $11,973,500,753 -$377,116,592 $47.94 700
2019 Q4 257,708,483 $13,039,312,900 -$299,685,598 $50.58 696
2019 Q3 263,058,388 $12,421,807,700 -$154,561,931 $47.19 646
2019 Q2 266,301,732 $12,549,277,578 +$112,663,414 $47.10 670
2019 Q1 266,393,534 $12,834,915,906 +$252,492,907 $48.15 681
2018 Q4 261,154,455 $11,654,601,270 -$346,197,680 $44.60 696
2018 Q3 269,053,754 $14,526,491,214 -$313,915,450 $54.00 674
2018 Q2 275,052,600 $13,431,885,876 -$812,897,126 $48.83 699
2018 Q1 288,649,333 $18,091,853,301 +$335,240,339 $62.68 729
2017 Q4 283,389,982 $17,364,246,502 +$63,286,907 $61.27 712
2017 Q3 281,127,333 $18,811,937,959 +$39,929,155 $66.92 700
2017 Q2 279,781,543 $21,801,515,155 +$216,562,861 $77.92 739
2017 Q1 277,112,823 $22,595,266,858 +$1,449,785,019 $81.55 758
2016 Q4 281,539,068 $20,271,420,850 +$253,260,316 $71.97 768
2016 Q3 276,212,521 $21,447,178,799 -$198,573,615 $77.70 764
2016 Q2 277,512,634 $21,660,605,322 -$34,301,853 $78.01 801
2016 Q1 277,508,153 $22,736,594,914 -$445,958,665 $81.95 784
2015 Q4 282,260,693 $25,199,053,280 -$446,903,454 $89.27 779
2015 Q3 286,505,487 $22,010,069,378 +$116,316,606 $76.82 751
2015 Q2 286,508,684 $23,968,072,171 -$91,304,996 $83.65 758
2015 Q1 287,672,722 $25,956,329,772 +$334,462,478 $90.27 727
2014 Q4 284,190,307 $22,949,941,596 -$643,355,007 $80.73 699
2014 Q3 291,369,100 $21,829,404,024 -$101,093,684 $74.92 631
2014 Q2 292,855,276 $20,082,090,867 +$125,635,349 $68.56 632
2014 Q1 290,975,888 $20,358,912,922 -$308,239,818 $69.98 640